By leveraging the prognostic information from this cohort alongside data from The Cancer Genome Atlas (TCGA), Kaplan-Meier survival analysis indicated that high expression levels of NLN are significantly correlated with poor prognosis in lung cancer (P < 0.001) (Fig. 1F and G). The gene discussed is NLN; the disease is lung cancer.